Niu Lizhi
- 4.6 優秀 • 17 レビュー
- 30年の経験
- 認定:
- 中国, 広州, Fuda Cancer Hospital
約10,000件の凍結手術を実施 – 牛立志教授は富大腫瘍医院の低侵襲治療プログラムを主導しています。
- 膵癌に対する凍結手術およびナノナイフ治療を専門とする
- アジア凍結手術学会および国際凍結手術学会の副会長
- 外科腫瘍学的手技に関する論文を100篇以上発表
- 凍結手術の革新に対し世界癌会議賞を受賞
- 続きを読む
約10,000件の凍結手術を実施 – 牛立志教授は富大腫瘍医院の低侵襲治療プログラムを主導しています。
Professor of oncosurgery and proctology
Fields of Study and Interests
Breast Cancer
Lung Cancer
Colon Cancer
Stomach Cancer
Rectum Cancer
Ovarian Cancer
Uterine Cancer
Liver Cancer
Esophageal Cancer - Esophagus Cancer
Kidney Cancer
Larynx Cancer - Throat Cancer
Thyroid Cancer
Head and Neck Cancers
Gynecological Cancers
Pancreatic Cancer
Esophageal Cancer - Esophagus Cancer
Uterine Cancer
Brain Cancers - Brain Tumors
Soft Tissue Cancer - Sarcomas
Prostate Cancer
Bladder Cancer
Bile Duct Cancer
Testicular Cancer
Cervical Cancer
Mouth, Tongue, Lip Cancers
Gastrointestinal System Cancers
Bone Tumors
Trachea and Bronchial Cancers
Skin Cancers - Skin Cancers
Skeletal System Tumors
Gallbladder Cancer
Mesothelioma
Education
Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Education and Research Hospital Internal Medicine Specialist, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Specialist, 2015
Career
MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center, USA 2022
Istanbul Haydarpaşa Education and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical University Faculty of Medicine Medical Oncology Clinic, 2015
Istanbul Göztepe Education and Research Hospital Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022
Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.
Dr. Klaus Kaczirek is a senior physician at the University Clinic for Surgery, Medical University of Vienna. He specializes in general and visceral surgery. He is known for his skill in hepatobiliopancreatic, oncological visceral, and endocrine surgery. His main focus is on complex operations involving the liver, pancreas, gastrointestinal tract, and endocrine organs.
Dr. Kaczirek holds board certifications in both general and visceral surgery. Since 2008, he has led the liver, gallbladder, and pancreas working group at the Austrian Society for Surgical Oncology. He is a member of the Austrian Society for Surgery, the European Society of Endocrine Surgeons, and other international surgical organizations. Dr. Kaczirek also reviews articles for leading medical journals and has helped advance surgical oncology and endocrine surgery.
Dr. Hossein Taghizadeh is a highly regarded Austrian specialist in internal medicine, hematology, and medical oncology, known for his compassionate approach and commitment to personalized cancer care. With extensive experience in treating solid tumors and blood cancers, he represents a new generation of oncologists who integrate scientific progress with empathy and precision.
He studied medicine at the Medical University of Vienna, graduating in 2016, and began his residency in internal medicine and oncology shortly thereafter. His academic and clinical training at leading Austrian cancer centers equipped him with deep expertise in systemic cancer therapy, hematologic diseases, and palliative medicine.
2010–2016 – Studied medicine at the Medical University of Vienna.
2018 – Began residency in internal medicine and medical oncology, focusing on individualized treatment strategies.
2020s – Specialized in solid tumors, hematologic malignancies, and targeted therapy, contributing to multidisciplinary oncology care.
Today – Practices as an oncologist at Oncodoc and Wiener Privatklinik, providing diagnostics, systemic treatment, and follow-up for patients with gastrointestinal, urogenital, and hematologic cancers.
Dr. Taghizadeh’s clinical interests include gastrointestinal tumors, pancreatic and biliary cancers, genitourinary malignancies, and hematologic neoplasms. He works with advanced diagnostic tools and modern systemic therapies, including chemotherapy, targeted therapy, and immunotherapy.
Known for his calm professionalism, integrity, and patient-centered communication, Dr. Taghizadeh places great emphasis on evidence-based medicine and emotional support throughout the treatment journey. His work reflects a modern, holistic approach to oncology — one that values both medical excellence and the human experience behind every diagnosis.
Prof. Dr. med. Karl J. Oldhaferは、アスクレピオス病院バルンベクにおける膵臓・肝臓・胃癌外科の第一人者です。
フォックス・ヴィオラ博士は、BKZゾーリンゲン血液腫瘍科・緩和医療科の主任医師です。同クリニックは、認定された集学的腫瘍センターです。フォックス博士は、ドイツおよびヨーロッパにおける腫瘍性疾患の薬物療法の第一人者であり、15年以上の臨床経験を有しています。
同博士は、ドイツ腫瘍学・血液腫瘍学会(GDHO)、ドイツ医師会、およびアメリカがん研究学会に所属しています。また、分子生物学の研究にも従事しており、その研究成果はがん治療および分子診断の発展に貢献しています。
主な専門領域は、化学療法、免疫療法、分子標的療法、および放射線療法です。フォックス博士は、革新的な治療法と患者への細やかな配慮で知られています。その取り組みにより、高い治癒率を達成し、同僚からの高い評価を得ています。
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Education
Ondokuz Mayıs University Faculty of Medicine (1991)
KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)
Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Education
Experience